Correlation Between Theseus Pharmaceuticals and C4 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Theseus Pharmaceuticals and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Theseus Pharmaceuticals and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Theseus Pharmaceuticals and C4 Therapeutics, you can compare the effects of market volatilities on Theseus Pharmaceuticals and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Theseus Pharmaceuticals with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Theseus Pharmaceuticals and C4 Therapeutics.

Diversification Opportunities for Theseus Pharmaceuticals and C4 Therapeutics

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Theseus and CCCC is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Theseus Pharmaceuticals and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Theseus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Theseus Pharmaceuticals are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Theseus Pharmaceuticals i.e., Theseus Pharmaceuticals and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Theseus Pharmaceuticals and C4 Therapeutics

If you would invest  371.00  in Theseus Pharmaceuticals on June 9, 2024 and sell it today you would earn a total of  0.00  from holding Theseus Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy4.55%
ValuesDaily Returns

Theseus Pharmaceuticals  vs.  C4 Therapeutics

 Performance 
       Timeline  
Theseus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Theseus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Theseus Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
C4 Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in C4 Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, C4 Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Theseus Pharmaceuticals and C4 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Theseus Pharmaceuticals and C4 Therapeutics

The main advantage of trading using opposite Theseus Pharmaceuticals and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Theseus Pharmaceuticals position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.
The idea behind Theseus Pharmaceuticals and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon